Share on LinkedInShare on LinkedIn

ARTICLE · 13 OCTOBER 2020

To Fee Or Not To Fee

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Contributor
Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP is one of the world’s largest firms focusing on...

View firm profile
Explore more from Finnegan, Henderson, Farabow, Garrett & Dunner LLP

In Amneal Pharmaceuticals LLC v. Almirall, LLC, the Federal Circuit determined that it cannot award attorneys' fees under 35 U.S.C. § 285 for work done on an underlying inter partes review (IPR).

United StatesIntellectual Property

In Amneal Pharmaceuticals LLC v. Almirall, LLC, the Federal Circuit determined that it cannot award attorneys' fees under 35 U.S.C. § 285 for work done on an underlying inter partes review (IPR).1 However, it also provided welcome guidance suggesting that district courts can, in limited circumstances, invoke § 285 to award attorneys' fees for parallel Patent Trial and Appeal Board (PTAB) proceedings. Yet the panel also refused to award fees accumulated at the Federal Circuit itself, supported by a rationale that district court judges may co-opt to deny attorneys' fees accumulated in related proceedings in other fora. We examine this decision in the context of district court orders finding for and against attorneys' fees awards for PTAB proceedings.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from